Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.22947
Abstract: To assess the usefulness of serum C‐terminal hydrolase L1 (UCH‐L1) level as a biomarker for predicting cognitive impairment in patients with acute organophosphorus pesticide poisoning (AOPP). read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Acta neurologica Belgica"
DOI: 10.1007/s13760-021-01644-y
Abstract: BACKGROUND Psoriatic arthritis (PsA) is an inflammatory rheumatic disorder associated with cutaneous psoriasis. Neurological manifestations are not uncommon in rheumatic diseases and recent studies point to a possible underestimation of cognitive impairment in this group… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "European Neuropsychopharmacology"
DOI: 10.1016/j.euroneuro.2021.10.476
Abstract: Objective. COVID-19 is increasingly recognized as a systemic disease, and we are seeing more and more disorders of the nervous system, one of which is cognitive impairment, which has a significant negative impact on mental… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "General hospital psychiatry"
DOI: 10.1016/j.genhosppsych.2020.05.011
Abstract: OBJECTIVE This study aims to systematically review the evidence on the accuracy of the Montreal Cognitive Assessment (MoCA) test for evaluating the presence of cognitive impairment in patients with schizophrenia and to outline the quality… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2020.08.028
Abstract: BACKGROUND The impact of cognitive status on outcomes of patients with atrial fibrillation (AF) is not well defined. AIMS To assess the prevalence of cognitive impairment in AF patients and evaluate its association with: i)… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Neurosurgery"
DOI: 10.1093/neuros/nyaa441
Abstract: BACKGROUND The Timed Up and Go (TUG) test is the most commonly applied objective measure of functional impairment in patients with lumbar degenerative disc disease (DDD). OBJECTIVE To demonstrate external content validity of the TUG… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Coronary Artery Disease"
DOI: 10.1097/mca.0000000000001049
Abstract: Supplemental Digital Content is available in the text. Background Cognitive impairment has been known to be associated with negative health impacts. Several studies recently demonstrated inconsistent outcomes among cognitive impaired patients with acute coronary syndrome… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Journal of Diabetes Investigation"
DOI: 10.1111/jdi.14010
Abstract: This study was carried out to investigate the relationship of stressful life events (SLEs) with the risk of cognitive impairment in patients with type 2 diabetes mellitus. read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "BMC Endocrine Disorders"
DOI: 10.1186/s12902-018-0314-7
Abstract: BackgroundCognitive impairment is commonly observed in patients with Hashimoto thyroiditis (HT). Low levels of vitamin D have been correlated with cognitive impairment in non-HT population. We examined the association of vitamin D levels with cognitive… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "International Journal of General Medicine"
DOI: 10.2147/ijgm.s407728
Abstract: Purpose This study aims to investigate the characteristics and influencing factors of cognitive impairment in patients with asymptomatic middle cerebral artery stenosis (aMCAS) and to construct a nomogram to predict the risk of cognitive impairment… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Reviews in cardiovascular medicine"
DOI: 10.31083/j.rcm2303098
Abstract: BACKGROUND There is controversy over whether non-vitamin K antagonist oral anticoagulants (NOACs) use increase the risk of hepatic impairment in patients with non-valvular atrial fibrillation (NVAF). We conducted a comprehensive assessment using multi-source medical data.… read more here.